FIB-AGE · Untangling fibroblast plasticity in vascular ageing
„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“
- Период
- 2021-06-01 → 2023-05-31
- Финансиране от ЕС
- 187 572 €
- Участници
- 1
- Схема
- MSCA-IF
Линиите свързват координатора с партньорите.
Накратко на български
Клетките в най-външния слой на кръвоносните съдове и тяхната роля при втвърдяването на стените им се анализират чрез нови генетични маркери. Това помага да се разбере как се развиват сърдечно-съдовите заболявания, причинени от стареенето.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Untangling fibroblast plasticity in vascular ageing
Everyone wants to grow old, but no one wants to feel old. In fact, age is the most important risk factor for cardiovascular disease, such as a heart attack or stroke. Yet there is no effective treatment to prevent age-associated changes leading to cardiovascular disease. The wall of a blood vessel consists of three layers. The inner two layers protect against clotting, accumulation of inflammatory cells, and help regulate blood pressure. The contribution of cells in the outer perivascular layer is still unknown. However, it is known that flexible blood vessels are essential for proper regulation of blood pressure and the proper functioning of the heart and organs. Aging is accompanied by the accumulation of connective tissue in the vessels, which leads to stiffness of the blood vessels. These stiff blood vessels are a significant cause of high blood pressure and the development of cardiovascular diseases such as heart attacks and strokes. This is particularly important now as people in our Western world are living longer but also want to experience it in good health. Current treatments are mainly aimed at the function of the two inner layers of the vessel wall and cannot prevent all heart attacks or strokes. We proposed that connective-tissue producing cells in the outer, perivascular cell layer play a causal role in vascular ageing. Therefore, we used advanced technology and identified new gene markers for these perivascular cells. We use modern technology to study changes in individual cells. With older technology, differences could not be observed because a large mix of whole tissues and all cell types was used. This is similar to a smoothie where the individual fruits cannot be seen anymore. This preliminary work demonstrates that there is indeed an increase in a specific group of connective tissue-producing cells during aging. This has led to the hypothesis that we will now investigate: Reprogramming the function of perivascular cells can reduce damage caused by vascular aging. We will study perivascular cell function in vivo, in vitro and in interventional studies ex vivo, in so far unimaginable detail. By sophisticated integration of this obtained data, we aim to identify key players promoting vascular ageing and dysfunction and suggest first interventional targets for future therapy to keep our vessels healthy for longer.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Vascular ageing is a major cause of cardiovascular disease, but effective treatment for fibrotic effects of vascular ageing is lacking. Recent studies show that fibroblasts exhibit physiological and pathological functions beyond their central role in fibrosis. Supporting this view of the field, the host lab recently showed great intra-vascular fibroblast plasticity in atherosclerotic and ageing murine arteries. We hypothesize that vascular dysfunction and fibrosis with ageing originate from altered fibroblast plasticity and function.As part of my career restart, I will join an excellent laboratory, globally recognized for its expertise in advanced vascular biology research, embedded in a modern research institute, equipped with outstanding training facilities. I will combine my acquired scientific, technical and management skills with the infrastructure and expertise of the host lab to comprehensively study ageing-related fibroblast plasticity and to reveal the function of distinct fibroblast subsets in vascular function and ageing. I will combine the hosts cutting-edge high throughput techniques, including single cell sequencing and a newly established fibroblast functionality screening platform (FIBROSCREEN), with my expertise in vascular contractility assessment. I will study fibroblast function and plasticity in vivo, in vitro and in interventional studies ex vivo, in so far unimaginable detail. By sophisticated integration of this obtained data, I will identify key fibroblast players promoting vascular ageing and dysfunction. With this strategy, I will be the first to reveal subsets of fibroblasts in vascular ageing, to couple their function to vascular ageing progression and to suggest first interventional targets for future exploitation. Together with career guidance by the host, concomitant training opportunities, and a clear plan for dissemination this will ensure my integration into European academia as an independent researcher.
Оригинален текст от CORDIS (на английски).
Участници
- UNIVERSITEIT MAASTRICHT · MaastrichtКоординаторНидерландия
Връзки
Данни: CORDIS, © Европейски съюз
